Healthcare Leaders Income ETF (HHL-T)

A good product that can be held. Would recommend as a portion of portfolio. Not a capital appreciation strategy - covered call reduces ability for share to appreciate. 

Great option for income oriented investors. However, would recommend diversifying with other names in portfolio. Overall direction of healthcare sector is strong. 

Good for healthcare exposure with dividend. Won't get high capital gains. But is a reliable product. 

Blue-chip basket of US healthcare names. Covered calls and leverage. Covered calls trade potential upside for potential income. If investor's ACB has gone down, could be because of return of capital.

The Harvest covered call ETFs start well, but then flatline. So, he has sold all his Harvest ETFs.

Healthcare sector lagging in the market, and is due for an increase in value. Very large companies with tailwind in aging population/demand for healthcare. Covered call strategy adds to yield. Good option for investors going forward. 

It was strictly a yield play when interest rates were so low. He has only a small position. Growth in the ETF can be somewhat restrained by the covered call structure. It's a tradeoff between yield and growth. He's still bullish on the healthcare sector, the demographics are beautiful.

Very good for healthcare exposure.
Actively managed with good performance.
High dividend yield (~10%).
Good for long term investors.